
Electrolux, the Swedish home appliances manufacturer, announced on Thursday that it had been fined €44.5 million ($46.3 million) by the French Competition Authority over allegations of antitrust violations. The fine stems from an investigation into practices between 2009 and 2014, according to Reuters. The company confirmed that the penalty was fully accounted for in a provision made in 2023.
The French Competition Authority stated that the alleged antitrust breaches involved activities that “reduced competition between distributors and kept prices artificially high for end-consumers.” This investigation targeted multiple firms in the industry, with Electrolux and its peers facing scrutiny over their business practices during the five-year period.
Per Reuters, Electrolux acknowledged the ongoing inquiry earlier and disclosed its potential implications. Ten out of the twelve implicated companies reportedly did not contest the accusations presented by the authority.
Related: Electrolux Settles French Antitrust Case For $60M
Groupe SEB, the owner of Tefal and Rowenta brands, received the largest fine of €189.5 million. Unlike most of the companies involved, Groupe SEB denied the allegations and stated its intention to appeal the ruling. Meanwhile, French retailer Fnac Darty, penalized with a €109 million fine, accepted the decision and announced plans to settle the payment in 2025 through short-term financing.
Requests for comments from Electrolux, Whirlpool, and LG went unanswered as of Thursday, Reuters reported.
Source: Reuters
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas